CureVac N.V. (CVAC)
Jan 6, 2026 - CVAC was delisted (reason: acquired by BNTX)
4.660
-0.010 (-0.21%)
Inactive · Last trade price on Jan 5, 2026
CureVac Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 2, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 1,049 | 765 | 943 | 1,147 | 6,418 | 14,306 | |
Market Cap Growth | 58.58% | -18.86% | -17.82% | -82.13% | -55.14% | - |
Enterprise Value | 602 | 590 | 496 | 657 | 5,253 | 13,292 |
Last Close Price | 4.66 | 3.41 | 4.21 | 6.03 | 34.31 | 81.07 |
Price Ratios
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 2, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
PE Ratio | 4.98 | 4.56 | - | - | - | - |
Forward PE | - | 3.04 | 13.22 | 13.22 | 13.22 | - |
PS Ratio | 9.02 | 1.38 | 15.87 | 15.92 | 54.79 | 239.30 |
PB Ratio | 0.82 | 1.06 | 1.65 | 2.01 | 8.20 | 16.44 |
P/TBV Ratio | 1.06 | 1.10 | 1.75 | 2.14 | 8.35 | 16.76 |
P/FCF Ratio | - | 8.44 | - | - | - | 24.06 |
P/OCF Ratio | - | 7.25 | - | - | - | 22.39 |
EV Ratios
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 2, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
EV/Sales Ratio | 7.26 | 1.06 | 8.35 | 9.12 | 44.85 | 222.35 |
EV/EBITDA Ratio | 2.65 | 2.56 | - | - | - | - |
EV/EBIT Ratio | 2.82 | 2.72 | - | - | - | - |
EV/FCF Ratio | - | 6.51 | - | - | - | 22.36 |
Financial Efficiency
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 2, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Debt / Equity Ratio | 0.04 | 0.06 | 0.08 | 0.08 | 0.04 | 0.08 |
Debt / EBITDA Ratio | 0.18 | 0.17 | - | - | - | - |
Debt / FCF Ratio | - | 0.45 | - | - | - | 0.11 |
Net Debt / Equity Ratio | -0.44 | -0.64 | -0.70 | -0.85 | -1.14 | -1.78 |
Net Debt / EBITDA Ratio | -1.97 | -1.99 | 1.45 | 2.20 | 0.77 | 10.30 |
Net Debt / FCF Ratio | 3.07 | -5.06 | 1.13 | 1.21 | 0.91 | -2.61 |
Asset Turnover | - | 0.67 | 0.07 | 0.07 | 0.08 | 0.06 |
Inventory Turnover | - | 8.34 | 4.76 | 3.97 | 6.09 | 1.37 |
Quick Ratio | 1.88 | 7.11 | 2.37 | 3.44 | 2.43 | 5.39 |
Current Ratio | 3.70 | 7.28 | 2.57 | 3.74 | 2.63 | 5.61 |
Return on Equity (ROE) | - | 26.73% | -49.55% | -40.77% | -58.82% | -38.63% |
Return on Assets (ROA) | - | 16.48% | -20.18% | -13.90% | -48.24% | -10.17% |
Return on Invested Capital (ROIC) | 41.40% | 86.92% | -225.67% | - | - | - |
Return on Capital Employed (ROCE) | 20.20% | 28.70% | -44.20% | -31.90% | -128.70% | -10.60% |
Yields
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 2, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Earnings Yield | 14.40% | 21.95% | -30.50% | -23.20% | -7.30% | -1.10% |
FCF Yield | -13.83% | 11.85% | -37.54% | -34.86% | -15.19% | 4.16% |
Buyback Yield / Dilution | 38.70% | -1.57% | -16.84% | -1.65% | -40.71% | -36.72% |